Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naloxegol for Opioid-Related Gastroparesis: A Double-Blind Study With an Open Label Extension

NCT03036891 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT03036891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03036891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naloxegol for Opioid-Related Gastroparesis: A Double-Blind Study With an Open Label Extension
Lead sponsor
Temple University
Phase
Phase 2
Overall status
Withdrawn
Start date
December 29, 2016
Completion date
September 30, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis, opioid use